Live Breaking News & Updates on Inflammation Immunology Discovery Biology

Stay updated with breaking news from Inflammation immunology discovery biology. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Agomab Therapeutics NV: Agomab Raises Additional $40.5 Million Through Series B Extension Bringing Total Amount to $114 Million

Extension led by Pfizer with participation from new investors Walleye Capital and Asabys Partners as well as existing investors Funding will support next stage of clinical and corporate development ....

Kostenloser Wertpapierhandel , Laura Mittmann , Tim Knotnerus , Thomas Wynn , Michael Vincent , Redmile Group , Trophic Communications , Pfizer Breakthrough Growth Initiative , Walleye Capital , Asabys Partners , Vice President , Inflammation Immunology Discovery Biology , Scientific Advisory , Chief Executive Officer , Origo Biopharma , Senior Vice President , Chief Scientific Officer , Inflammation Immunology , Agomab Therapeutics ,